[Carcinoma in situ of the bladder involving the prostate with an unusual invasive pattern following BCG therapy: a case report].

We report a case of carcinoma in situ (CIS) of the bladder involving the prostate with an unusual invasive pattern following Bacillus Calmette Guerin (BCG) therapy. A 41-year-old man achieved complete response after a course of intravesical instillation of BCG for diffuse CIS of the bladder. Two years later, urine cytology became positive. We performed random biopsy of the bladder and urethra three times and examined the bilateral upper urinary tract with retrograde pyelography and split urine cytology. However, none of these examinations revealed any malignant features, leading to a suspicion that the prostate was the recurrent site. Transrectal needle biopsy of the prostate revealed urothelial carcinoma (UC) at the transition between bladder and prostate. Transurethral biopsy of the prostatic urethra also detected UC in a core of the bladder neck only. Under a diagnosis of UC involving the prostate, we performed total cystectomy with ileal conduit diversion. Histopathological findings of the surgical specimen showed prostatic stromal invasion of the tumor. In this case, CIS at the bladder neck might directly and silently invade the prostatic stroma, thus transurethral biopsy contributed little to the diganosis. We recommend transrectal needle biopsy of the prostate as well as TUR biopsy in such rare cases.

[1]  J. Jamart,et al.  Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. , 2003, The Journal of urology.

[2]  H. Herr,et al.  The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. , 2001, The Journal of urology.

[3]  V. Reuter,et al.  Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. , 2001, The Journal of urology.

[4]  G. Steinberg,et al.  The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder. , 2001, The Journal of urology.

[5]  P. Schellhammer PROSTATIC TUMOR RELAPSE IN PATIENTS WITH SUPERFICIAL BLADDER TUMORS: 15-YEAR OUTCOME , 1999 .

[6]  Michael Cookson,et al.  Upper tract tumors in patients with primary bladder cancer followed for 15 years. , 1996, The Journal of urology.

[7]  S. Groshen,et al.  Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. , 1996, The Journal of urology.

[8]  J. Palou,et al.  In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guérin therapy without previous transurethral resection of the prostate. , 1996, Urology.

[9]  M. Soloway,et al.  Transitional cell carcinoma of the prostate. , 1991, The Journal of urology.

[10]  H. Levin,et al.  Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study. , 1989, The Journal of urology.

[11]  M. Melamed,et al.  Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra. , 1989, The Journal of urology.

[12]  H. Herr Carcinoma in situ of the bladder. , 1983, Seminars in urology.